Skip to main content
. 2022 May 23;14(5):e25243. doi: 10.7759/cureus.25243

Figure 2. Membranous PD-L1 positivity in tumor cells. (A): 1+ (mild) positivity in tumor cells (IHC X400). (B): 2+ (moderate) positivity in tumor cells (IHC X400). (C): 3+ (strong) positivity in tumor cells (IHC X100).

Figure 2

PD-L1: Programmed death-ligand 1; IHC: Immunohistochemistry.